Breathe Technologies (San Ramon, CA) a commercial-stage medical device company focused on therapeutic respiratory systems for the treatment of COPD and sleep apnea, closed a $23M Series C financing. Participants include DAG Ventures, Kleiner Perkins Caufield & Byers, Delphi Ventures, Synergy Ventures and Johnson & Johnson Development Corp..
Apnex Medical (St. Paul, MN) a clinical-stage medical device company developing an implantable treatment for moderate-to-severe obstructive sleep apnea, closed a $14M Series B financing. Participants include Domain Associates, New Enterprise Associates and Polaris Venture Partners. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb
Sleep Solutions (Glen Burnies, MD) a commercial-stage medical device and diagnostics company focused on obstructive sleep apnea, closed a $20M Series F financing. Participants include Quaker BioVentures, Johnson & Johnson Dev Corp., TPG Growth, MedVenture Associates, Emergent Ventures and Lava Ventures.